Furthermore, the silencing of METTL14 significantly increased the anti-tumor effects induced by oHSV-1, indicating that the METTL14/ISG15 pathway may serve as a promising therapeutic target for HSV-1 infections. The gene discussed is METTL14; the disease is neoplasm.